Meleha Ahmad, MD
Ophthalmology · Kansas City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 3
- Since medical school
- 9 years
- New York University School of Medicine, 2017
Offices
3 locations · Moyes Eye Center, P.C. · University Health Physicians
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahmad’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A172879 · Delinquent
Licence status: Delinquent · since 2021 · expires 2025-05-31 · New York University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Ophthalmology - Ophthalmology
Original Medicare doctor bills
$117,120
Medicare paid this office $117,120 for 323 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of excessive skin and fat of upper eyelid | 62 | $37,109 | $599 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 28 | $11,650 | $388 |
| New patient visit (45+ min) | 89 | $9,172 | $103 |
| Return visit (30+ min) | 72 | $7,440 | $91 |
| Removal of growth of eyelid | 36 | $7,058 | $191 |
See all 14 services
| Removal of excessive skin and fat of upper eyelid | 62 | $37,109 | $599 |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | 28 | $11,650 | $388 |
| New patient visit (45+ min) | 89 | $9,172 | $103 |
| Return visit (30+ min) | 72 | $7,440 | $91 |
| Removal of growth of eyelid | 36 | $7,058 | $191 |
| Extensive repair of turning-outward eyelid defect | 16 | $6,044 | $378 |
| Short return visit (20+ min) | 81 | $6,013 | $66 |
| Photography of content of eyes | 166 | $2,905 | $16 |
| Exam of visual field with limited testing | 138 | $2,811 | $19 |
| Established patient problem focused exam of visual system | 32 | $2,217 | $65 |
| Dilation of tear drainage opening | 22 | $2,052 | $89 |
| New patient visit (30+ min) | 27 | $1,954 | $72 |
| Short return visit | 44 | $1,890 | $39 |
| New patient problem focused exam of visual system | 23 | $1,210 | $53 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Removal of excessive skin and fat of upper eyelid | – | – | – | 62 |
| Removal of growth of eyelid | – | – | 16 | 37 |
| Probing of nasal tear duct | – | 21 | 14 | – |
| Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | – | – | – | 30 |
| Dilation of tear drainage opening | – | – | – | 23 |
| Extensive repair of turning-outward eyelid defect | – | – | – | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
323 Original Medicare patients in 2024. Average age 75 · Women 72% · Health risk score 1.10. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 74% · Diabetes 28% · Coronary heart disease 28% · Depression 23% · Chronic kidney disease 22% · COPD 17% · Atrial fibrillation 16% · Cancer 14% · Heart failure 13% · Stroke 7%.
The office billed $506,350, Medicare allowed $154,185 and paid $117,120; for 1,405 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 323 | 1,405 | 75 | 1.10 | $506,350 | $117,120 |
| 2023 | 163 | 374 | 74 | 1.21 | $160,560 | $34,539 |
| 2022 | 129 | 160 | 75 | 1.43 | $121,239 | $9,418 |
| 2021 | 38 | 44 | 71 | 1.67 | $47,162 | $3,047 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| New patient visit (45+ min) | 32 | $4,002 | $125 |
| Removal of growth of eyelid | 15 | $3,081 | $193 |
| Return visit (30+ min) | 27 | $2,605 | $96 |
| Established patient problem focused exam of visual system | 45 | $1,841 | $38 |
| Probing of nasal tear duct | 13 | $1,459 | $104 |
| Photography of content of eyes | 61 | $1,037 | $16 |
| Exam of visual field with limited testing | 42 | $936 | $22 |
| Short return visit (20+ min) | 13 | $931 | $67 |
| New patient visit (30+ min) | 11 | $920 | $84 |
| New patient problem focused exam of visual system | 17 | $805 | $47 |
| Exam of visual field with extended testing | 15 | $339 | $23 |
2022: 3 services
| Probing of nasal tear duct | 20 | $2,095 | $100 |
| Established patient problem focused exam of visual system | 27 | $1,211 | $42 |
| Exam of visual field with extended testing | 55 | $1,158 | $21 |
2021: 1 service
| Exam of visual field with extended testing | 16 | $403 | $25 |
Drugs they prescribed that Part D paid
$433,673
Pharmacies billed $433,673 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 471) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
426 generic and 45 brand-name prescriptions · $433,673 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Erythromycin | 226 | $3,391 | $10 |
| Neomycin-Polymyxin-Dexameth | 42 | $576 | $11 |
Year by year
| 2024 | 471 | 264 | 0% (0) | 10% | $433,673 |
| 2023 | 205 | 127 | None | 12% | $2,907 |
| 2022 | 354 | 194 | None | 4% | $5,895 |
| 2021 | 322 | 156 | None | 26% | $8,599 |
| 2020 | 271 | 95 | None | 32% | $12,180 |
| 2019 | 228 | 93 | None | 28% | $18,576 |
| 2018 | 103 | 49 | None | 27% | $6,587 |
| 2017 | 53 | 21 | 0% (0) | None | $719 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Erythromycin | 122 | $1,308 | $11 |
| Neomycin-Polymyxin-Dexameth | 25 | $396 | $16 |
2022: 3 drugs
| Erythromycin | 248 | $2,515 | $10 |
| Neomycin-Polymyxin-Dexameth | 43 | $686 | $16 |
| Prednisone | 13 | $101 | $8 |
2021: 6 drugs
| Prednisolone Acetate | 59 | $2,193 | $37 |
| Erythromycin | 109 | $1,248 | $11 |
| Neomycin-Polymyxin-Dexameth | 27 | $476 | $18 |
| Ketorolac Tromethamine | 25 | $386 | $15 |
| Latanoprost | 17 | $234 | $14 |
| Ciprofloxacin | 16 | $150 | $9 |
2020: 6 drugs
| Prednisolone Acetate | 63 | $2,327 | $37 |
| Latanoprost | 42 | $653 | $16 |
| Ofloxacin | 36 | $413 | $11 |
| Ketorolac Tromethamine | 25 | $362 | $14 |
| Erythromycin | 27 | $318 | $12 |
| Brimonidine | 17 | $160 | $9 |
2019: 6 drugs
| Latanoprost | 67 | $1,176 | $18 |
| Prednisolone Acetate | 19 | $746 | $39 |
| Timolol Maleate | 17 | $322 | $19 |
| Dorzolamide-Timolol | 12 | $275 | $23 |
| Erythromycin | 23 | $269 | $12 |
| Brimonidine | 17 | $252 | $15 |
2018: 1 drug
| Latanoprost | 14 | $218 | $16 |
Money from drug and device companies
$327 in 2025
| 2025 | 2 | 8 | None | $327 |
| 2024 | 3 | 21 | None | $2,231 |
| 2023 | 3 | 7 | None | $317 |
| 2022 | 2 | 2 | None | $221 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tepezza | $202 | 7 payments
|
| Alcon Vision | Clareon | $124 | 1 payment
|
See all 8 published payments
| Amgen | Meals · 2025-12-17 | Tepezza | $7 |
| Amgen | Meals · 2025-11-25 | Tepezza | $14 |
| Amgen | Meals · 2025-11-11 | Tepezza | $12 |
| Amgen | Meals · 2025-09-30 | Tepezza | $18 |
| Amgen | Meals · 2025-06-20 | Tepezza | $27 |
| Amgen | Meals · 2025-05-01 | Tepezza | $104 |
| Amgen | Meals · 2025-04-22 | Tepezza | $19 |
| Alcon Vision | Meals · 2025-02-20 | Clareon | $124 |
See earlier years (2024, 2023, 2022)
2024: $2,231
| Argenx US | Vyvgart | $1,549 | 10 payments
|
| Amgen | Tepezza | $527 | 9 payments
|
| Alcon Vision | Clareon | $155 | 2 payments
|
2023: $317
| Horizon Therapeutics plc | Tepezza | $181 | 5 payments
|
| Sun Pharmaceutical Industries | Cequa | $120 | 1 payment
|
| Alcon Vision | Constellation | $16 | 1 payment
|
2022: $221
| Abbvie | None | $202 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1295267714
- Licence
- CA A172879California A172879: Delinquent · expires 2025-05-31
- Trained
- New York University School of Medicine, 2017 · 9 years ago
- Group
- Moyes Eye Center, P.C. · University Health Physicians
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); Student in a training program (390200000X)
- Mailing address
- 5151 Nw 88th St, Kansas City, MO, 64154
- NPI first listed
- 2017-04-03
- NPI last updated
- 2026-04-24
- NPI record certified
- 2026-04-24
This is when the NPI record was last certified, not a medical board exam.